As Congress prods Mylan over EpiPen in the latest probe on prescription prices, the pharmaceutical industry's massive lobbying spend gets put to the test. Gina Chon and Jeffrey Goldfarb discuss.
from Reuters Video: Breakingviews http://ift.tt/2clpS8l
via
IFTTT
No comments:
Post a Comment